Want to join the conversation?
The current vaccine portfolio of Boehringer Ingelheim Vetmedica Inc., which is to be acquired by Elanco U.S. Inc., a subsidiary of $LLY, has experienced revenue growth over the past three years. $LLY expects the deal to add to GAAP earnings in 2019 and to non-GAAP earnings in 2018.
Looking forward for $STT’s 2017 first quarter earnings results. Is it possible for them to outperform their estimates?
$HAL has cautioned that its 1Q profit is likely to miss projections. I’m expecting EPS to be in low single digits.!
$GOOG is losing more advertisers after the boycotts over extremist ads. Future is not so bright for Google in the advertising sector..!